Olema Pharmaceuticals inc (OLMA)
10.67
+0.60
(+5.96%)
USD |
NASDAQ |
May 03, 16:00
10.66
-0.01
(-0.09%)
After-Hours: 20:00
Olema Pharmaceuticals Price to Book Value: 2.350 for May 3, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 03, 2024 | 2.350 |
| May 02, 2024 | 2.218 |
| May 01, 2024 | 2.290 |
| April 30, 2024 | 2.240 |
| April 29, 2024 | 2.238 |
| April 26, 2024 | 2.191 |
| April 25, 2024 | 2.165 |
| April 24, 2024 | 2.235 |
| April 23, 2024 | 2.202 |
| April 22, 2024 | 2.174 |
| April 19, 2024 | 2.187 |
| April 18, 2024 | 2.180 |
| April 17, 2024 | 2.359 |
| April 16, 2024 | 2.383 |
| April 15, 2024 | 2.390 |
| April 12, 2024 | 2.392 |
| April 11, 2024 | 2.544 |
| April 10, 2024 | 2.409 |
| April 09, 2024 | 2.539 |
| April 08, 2024 | 2.482 |
| April 05, 2024 | 2.356 |
| April 04, 2024 | 2.315 |
| April 03, 2024 | 2.440 |
| April 02, 2024 | 2.387 |
| April 01, 2024 | 2.398 |
| Date | Value |
|---|---|
| March 28, 2024 | 2.493 |
| March 27, 2024 | 2.467 |
| March 26, 2024 | 2.412 |
| March 25, 2024 | 2.416 |
| March 22, 2024 | 2.473 |
| March 21, 2024 | 2.544 |
| March 20, 2024 | 2.561 |
| March 19, 2024 | 2.544 |
| March 18, 2024 | 2.440 |
| March 15, 2024 | 2.544 |
| March 14, 2024 | 2.548 |
| March 13, 2024 | 2.753 |
| March 12, 2024 | 2.674 |
| March 11, 2024 | 2.863 |
| March 08, 2024 | 2.863 |
| March 07, 2024 | 3.099 |
| March 06, 2024 | 3.100 |
| March 05, 2024 | 2.996 |
| March 04, 2024 | 3.154 |
| March 01, 2024 | 3.206 |
| February 29, 2024 | 2.686 |
| February 28, 2024 | 2.809 |
| February 27, 2024 | 2.972 |
| February 26, 2024 | 2.931 |
| February 23, 2024 | 2.922 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.3105
Minimum
May 11 2022
17.46
Maximum
Dec 01 2020
2.554
Average
2.284
Median
Price to Book Value Benchmarks
| Geron Corp | 6.759 |
| Verastem Inc | 4.808 |
| Fate Therapeutics Inc | 1.094 |
| Karyopharm Therapeutics Inc | -- |
| Alpine Immune Sciences Inc | 12.91 |
Price to Book Value Related Metrics
| Price | 10.67 |
| Earnings Yield | -20.15% |
| Market Cap | 596.61M |